Ameriprise Financial Inc Alkermes Plc. Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Alkermes Plc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 480,960 shares of ALKS stock, worth $14.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

480,960

Previous 550,146 12.58%

Holding current value

$14.3 Million

Previous $13.3 Million 1.54%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$23.01 - $28.55 $1.59 Million - $1.98 Million	-69,186 Reduced 12.58%	480,960 $13.5 Million
Q2 2024 Aug 14, 2024	SELL	$23.21 - $27.24 $1.2 Million - $1.41 Million	-51,825 Reduced 8.61%	550,146 $13.3 Million
Q1 2024 May 15, 2024	SELL	$26.4 - $32.56 $1.42 Million - $1.75 Million	-53,738 Reduced 8.2%	601,971 $16.3 Million
Q4 2023 Feb 14, 2024	BUY	$23.37 - $28.68 $10.2 Million - $12.5 Million	435,075 Added 197.19%	655,709 $18.2 Million
Q3 2023 Nov 14, 2023	SELL	$27.17 - $31.97 $101,914 - $119,919	-3,751 Reduced 1.67%	220,634 $6.18 Million
Q2 2023 Aug 14, 2023	BUY	$28.34 - $33.63 $87,598 - $103,950	3,091 Added 1.4%	224,385 $7.02 Million
Q1 2023 May 15, 2023	BUY	$25.31 - $29.02 $327,891 - $375,954	12,955 Added 6.22%	221,294 $6.24 Million
Q4 2022 Feb 14, 2023	SELL	$21.94 - $26.24 $4.37 Million - $5.23 Million	-199,271 Reduced 48.89%	208,339 $5.44 Million
Q3 2022 Nov 14, 2022	SELL	$22.0 - $31.87 $963,644 - $1.4 Million	-43,802 Reduced 9.7%	407,610 $9.1 Million
Q2 2022 Aug 15, 2022	BUY	$26.4 - $30.54 $4.68 Million - $5.42 Million	177,350 Added 64.71%	451,412 $13.4 Million
Q1 2022 May 16, 2022	SELL	$23.07 - $27.99 $190,950 - $231,673	-8,277 Reduced 2.93%	274,062 $7.21 Million
Q4 2021 Feb 14, 2022	BUY	$21.47 - $32.08 $3.79 Million - $5.67 Million	176,732 Added 167.35%	282,339 $6.57 Million
Q3 2021 Nov 15, 2021	BUY	$23.37 - $32.13 $86,305 - $118,656	3,693 Added 3.62%	105,607 $3.26 Million
Q2 2021 Aug 16, 2021	BUY	$18.78 - $25.15 $29,371 - $39,334	1,564 Added 1.56%	101,914 $2.5 Million
Q1 2021 May 17, 2021	SELL	$18.21 - $23.2 $201,839 - $257,148	-11,084 Reduced 9.95%	100,350 $1.88 Million
Q4 2020 Feb 12, 2021	SELL	$15.39 - $22.1 $55,650 - $79,913	-3,616 Reduced 3.14%	111,434 $2.22 Million
Q3 2020 Nov 16, 2020	BUY	$16.16 - $20.66 $35,309 - $45,142	2,185 Added 1.94%	115,050 $1.91 Million
Q2 2020 Aug 14, 2020	SELL	$13.31 - $19.41 $435,237 - $634,707	-32,700 Reduced 22.46%	112,865 $2.19 Million
Q1 2020 May 15, 2020	BUY	$13.06 - $21.24 $705,070 - $1.15 Million	53,987 Added 58.95%	145,565 $2.1 Million
Q4 2019 Feb 14, 2020	BUY	$17.29 - $21.74 $1.58 Million - $1.99 Million	91,578 New	91,578 $1.87 Million
Q3 2019 Nov 14, 2019	SELL	$19.51 - $24.28 $219,741 - $273,465	-11,263 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$21.47 - $37.33 $12 Million - $20.9 Million	-559,407 Reduced 98.03%	11,263 $255,000
Q1 2019 May 15, 2019	SELL	$28.4 - $36.49 $5.75 Million - $7.39 Million	-202,406 Reduced 26.18%	570,670 $20.8 Million
Q4 2018 Feb 14, 2019	BUY	$27.94 - $44.61 $20.1 Million - $32.1 Million	719,199 Added 1334.89%	773,076 $22.8 Million
Q3 2018 Nov 14, 2018	SELL	$38.6 - $46.12 $18.7 Million - $22.4 Million	-485,301 Reduced 90.01%	53,877 $2.29 Million
Q2 2018 Aug 14, 2018	SELL	$40.56 - $51.36 $19.3 Million - $24.4 Million	-475,196 Reduced 46.85%	539,178 $22.2 Million
Q1 2018 May 15, 2018	BUY	$53.61 - $67.26 $30.2 Million - $37.9 Million	564,103 Added 125.28%	1,014,374 $58.8 Million
Q4 2017 Feb 12, 2018	SELL	$47.69 - $55.39 $4.45 Million - $5.16 Million	-93,215 Reduced 17.15%	450,271 $24.6 Million
Q3 2017 Nov 07, 2017	BUY	$49.16 - $54.45 $26.7 Million - $29.6 Million	543,486	543,486 $27.6 Million

Others Institutions Holding ALKS

# of Institutions

362

Shares Held

181M

Call Options Held

175K

Put Options Held

96.6K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.88B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Alkermes Plc. Transaction History